India Ratings Affirms Chemfab Alkalis' Bank Loan Facilities at IND BBB+/Negative
India Ratings has affirmed Chemfab Alkalis Limited's bank loan facilities rating at IND BBB+/Negative/IND A2. The negative outlook is due to a slower-than-expected recovery in the OPVC pipe business, impacting consolidated operating performance. However, an expected recovery in the coming months and improved performance in the chlor-alkali segment provide some support. Liquidity remains stretched.
The credit rating affirmation with a negative outlook indicates a stable but potentially deteriorating credit profile. This could impact the company's borrowing costs and access to future financing, but it does not represent an immediate severe financial distress.
The rating affirmation is accompanied by a 'Negative' outlook due to the slower-than-expected recovery in the company's operating performance, particularly in the OPVC pipe business, and the resulting weakening of credit metrics and stretched liquidity.
India Ratings and Research (Ind-Ra) has affirmed Chemfab Alkalis Limited’s (CAL) bank loan facilities rating at IND BBB+/Negative/IND A2. The Negative Outlook reflects a slower-than-expected recovery in CAL’s consolidated operating performance in FY26 and 1QFY27, attributed to prolonged weakness in the oriented polyvinyl chloride (OPVC) pipe business. Significant investments in capacity expansion have led to underutilization due to lower-than-expected demand related to the Jal Jeevan Mission (JJM).
Despite these challenges, the affirmation acknowledges Ind-Ra's expectation of a meaningful recovery in operating performance over the coming months and the availability of liquidity buffers. CAL's order book has shown early signs of recovery, with an outstanding position of around INR170 million at end-September 2026. The company has also benefited from incremental capex reimbursement borrowings of INR555 million in 1HFY27.
The chlor-alkali segment showed improvement in 1QFY27, driven by price increases and the commissioning of a new membrane electrolyser and power-efficiency initiatives. While caustic soda prices have corrected, cost efficiency measures are expected to support continued profitability improvement in this segment. CAL has completed the replacement of an old electrolyser and commissioned a hybrid power project, expected to yield significant cost savings. Further capex is underway to optimize the new electrolyser's performance, targeting additional cost savings.
The OPVC pipe business, however, continues to face challenges due to weak JJM-linked demand, leading to low capacity utilization and reduced revenue. CAL has expanded its OPVC pipe capacity significantly, but the segment's revenue share has fallen. The management is pursuing diversification through non-JJM government and private-sector projects.
CAL's credit metrics have weakened due to increased capex without commensurate revenue and profitability improvement, with net leverage rising to 4.0x at FYE26. The gross interest cover has also deteriorated. The company's liquidity position is considered stretched, with declining unencumbered cash and reliance on working capital facilities. Planned monetization of non-core assets could provide additional liquidity support.
What to do with a filing like this
Chemfab Alkalis Limited filed this with the NSE as a statutory disclosure, categorised under credit ratings. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Chemfab Alkalis Limited. Read the original for the full detail.